Predictions
Ocuphire Pharma Inc.
Start price
Target price
Perf. (%)
€3.20
10.01.23
10.01.23
€6.00
31.12.25
31.12.25
-28.13%
26.01.23
26.01.23
Could be very worthwhile Investment >20% year
Immunogen Inc.
Start price
Target price
Perf. (%)
€3.98
09.01.23
09.01.23
€8.00
31.12.25
31.12.25
178.89%
05.05.23
05.05.23
Could be very worthwhile Investment >20% year
BayWa AG VNA
Start price
Target price
Perf. (%)
€42.80
09.01.23
09.01.23
-
09.02.27
09.02.27
-34.81%
11.03.24
11.03.24
Could be worthwhile Investment >10% per year
Plug Power Inc.
Start price
Target price
Perf. (%)
€12.84
09.01.23
09.01.23
€20.00
09.01.24
09.01.24
15.30%
21.01.23
21.01.23
Good rating
Growths much faster than the competition
Leading role in innovation
Very good company culture
Bed Bath & Beyond Inc.
Start price
Target price
Perf. (%)
€1.76
09.01.23
09.01.23
-
09.01.24
09.01.24
74.24%
21.01.23
21.01.23
Capable Management
Good culture
Could be worthwhile Investment >10% per year
Little innovation
Galaxy Digital Holdings Ltd.
Start price
Target price
Perf. (%)
€3.07
09.01.23
09.01.23
-
20.04.26
20.04.26
131.22%
12.01.24
12.01.24
Very high cyclical dependencies
Probably not worthwhile Investment
Marathon Digital Holdings
Start price
Target price
Perf. (%)
€3.82
09.01.23
09.01.23
-
09.01.24
09.01.24
106.03%
17.01.23
17.01.23
Could be worthwhile Investment >10% per year
Very high cyclical dependencies
Drägerwerk AG & Co. KGaA VZO
Start price
Target price
Perf. (%)
€43.10
09.01.23
09.01.23
-
09.01.24
09.01.24
-0.35%
21.01.23
21.01.23
Market Leader or Top 3
Well known brand
Very Future proof/growth oriented business model
Revenue growth > 30% per year expected
Drägerwerk AG & Co. KGaA ST
Start price
Target price
Perf. (%)
€38.00
09.01.23
09.01.23
-
09.01.24
09.01.24
-1.05%
21.01.23
21.01.23
Fair valuation
Top 10 in its market
Future proof or reliable business model
Could be worthwhile Investment >10% per year
Marathon Digital Holdings
Start price
Target price
Perf. (%)
€3.86
08.01.23
08.01.23
-
08.01.24
08.01.24
100.00%
17.01.23
17.01.23
Risky Investment
Kulicke & Soffa Industries Inc.
Start price
Target price
Perf. (%)
€42.29
06.01.23
06.01.23
€54.00
06.01.24
06.01.24
13.27%
25.05.23
25.05.23
Could be very worthwhile Investment >20% year
Undervalued
Capable Management
Significant cyclical dependencies
AT&S Austria Technologie & Systemtechnik AG
Start price
Target price
Perf. (%)
€33.70
06.01.23
06.01.23
€40.00
06.01.24
06.01.24
0.30%
07.01.23
07.01.23
Revenue growth >5% per year expected
EBIT growth >5% per year expected
Undervalued
High Investments for future growth
Cytomx Therapeutics Inc
Start price
Target price
Perf. (%)
€1.73
05.01.23
05.01.23
€3.00
31.12.25
31.12.25
37.80%
06.01.23
06.01.23
Could be very worthwhile Investment >20% year
Aurinia Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€6.46
04.01.23
04.01.23
€12.00
31.12.25
31.12.25
63.49%
05.05.23
05.05.23
Could be very worthwhile Investment >20% year
Kala Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€39.20
04.01.23
04.01.23
-
04.01.24
04.01.24
-60.00%
20.01.23
20.01.23
Could be worthwhile Investment >10% per year
Marathon Digital Holdings
Start price
Target price
Perf. (%)
€3.68
04.01.23
04.01.23
€5.00
31.12.25
31.12.25
25.54%
09.01.23
09.01.23
Could be very worthwhile Investment >20% year
Kala Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€24.80
04.01.23
04.01.23
-
04.01.24
04.01.24
-33.71%
22.01.23
22.01.23
Geron Corp.
Start price
Target price
Perf. (%)
€2.80
04.01.23
04.01.23
-
04.01.24
04.01.24
-29.37%
02.04.23
02.04.23
Risky Investment
Geron Corp.
Start price
Target price
Perf. (%)
€2.50
04.01.23
04.01.23
€6.00
31.12.25
31.12.25
38.38%
04.01.23
04.01.23
Could be very worthwhile Investment >20% year
Rigel Pharmaceutical Inc.
Start price
Target price
Perf. (%)
€1.27
03.01.23
03.01.23
-
03.01.24
03.01.24
-5.60%
08.01.23
08.01.23
Could be worthwhile Investment >10% per year
Meta Material Inc.
Start price
Target price
Perf. (%)
€1.04
03.01.23
03.01.23
-
03.02.23
03.02.23
-6.57%
24.01.23
24.01.23
Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
EBIT growth >5% per year expected
Higher EBIT margin than peer group
Aurinia Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€5.55
03.01.23
03.01.23
-
03.01.24
03.01.24
78.44%
14.05.23
14.05.23
Could be worthwhile Investment >10% per year